MTCH2 and central nervous system cancer: Consistent with the fact that MTCH2 expression increased in glioma tissues, Kaplan–Meier survival analysis for multiple human glioma datasets (TCGA and CGGA) showed that patients with lower MTCH2 expression displayed significantly better overall survival than those with higher MTCH2 expression (Fig. 1e–f).